244 related articles for article (PubMed ID: 16860440)
1. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease.
Kantarci K; Weigand SD; Petersen RC; Boeve BF; Knopman DS; Gunter J; Reyes D; Shiung M; O'Brien PC; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
Neurobiol Aging; 2007 Sep; 28(9):1330-9. PubMed ID: 16860440
[TBL] [Abstract][Full Text] [Related]
2. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
[TBL] [Abstract][Full Text] [Related]
3. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
5. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
7. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
[TBL] [Abstract][Full Text] [Related]
8. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes.
Kantarci K; Petersen RC; Przybelski SA; Weigand SD; Shiung MM; Whitwell JL; Negash S; Ivnik RJ; Boeve BF; Knopman DS; Smith GE; Jack CR
Arch Neurol; 2008 Dec; 65(12):1621-8. PubMed ID: 19064749
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
11. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
[TBL] [Abstract][Full Text] [Related]
12. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
[TBL] [Abstract][Full Text] [Related]
13. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
[TBL] [Abstract][Full Text] [Related]
14. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
16. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
17. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
Modrego PJ; Fayed N; Pina MA
Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
[TBL] [Abstract][Full Text] [Related]
20. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
